Stroke, Vol 20, 1279-1283, Copyright © 1989 by American Heart Association
NM Ramadan, R Deveshwar and SR Levine
MRI is becoming the imaging modality of choice in patients with ischemic
cerebrovascular disease although CT is still the test of choice to exclude
acute hemorrhagic stroke. We have briefly reviewed characteristic features
of ischemic and hemorrhagic cerebrovascular disease as well as vascular
anomalies as seen on MRI. In time MRS should provide useful noninvasive
metabolic data to complement the anatomical data in patients with
cerebrovascular disease.
ARTICLES
Magnetic resonance and clinical cerebrovascular disease. An update
Department of Neurology, Henry Ford Hospital, Detroit, Michigan.
This article has been cited by other articles:
![]() |
A. J. Johnson, D. K. Kido, W. D. Shannon, M. M. Bahn, M. H. Gado, B. C. P. Lee, C. J. Moran, F. J. Wippold, and B. Littenberg Evaluation of a Reduced MR Imaging Sequencing Protocol in Adult Patients with Stroke Radiology, March 1, 2001; 218(3): 791 - 797. [Abstract] [Full Text] |
||||
![]() |
A.E. Baird, M.C. Austin, W.J. McKay, G.A. Donnan, and G.A. Donnan Sensitivity and Specificity of 99mTc-HMPAO SPECT Cerebral Perfusion Measurements During the First 48 Hours for the Localization of Cerebral Infarction Stroke, May 1, 1997; 28(5): 976 - 980. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |